Testing digoxin for medulloblastoma that came back in kids and young adults
Official title: Digoxin Medulloblastoma Study
Status: Recruiting. It is looking for patients now. Talk to your care team about whether it fits you.
The trial team last updated this record on .
The short version
This study is testing a drug called digoxin in young people whose medulloblastoma came back.
Read our full plain-language summary
What the trial team says
The purpose of this study is to evaluate the efficacy of digoxin in treating relapsed non-SHH, non-WNT medulloblastoma in pediatric and young adult patients.
Key facts
- Registry number
- NCT06701812
- Stage of testing
- Phase 2
- Conditions studied
- Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Where it is running
This trial lists 17 sites.
-
Alabama
- University of Alabama at Birmingham Children's of Alabama (Birmingham)
-
Arizona
- Phoenix Childrens Hospital (Phoenix)
-
Arkansas
- Arkansas Childrens Hospital (Little Rock)
-
Connecticut
- Connecticut Children's Medical Center (Hartford)
-
District of Columbia
- Children's National Medical Center (Washington D.C.)
-
Florida
- Nemours Jacksonville (Jacksonville)
- University of Miami (Miami)
- Johns Hopkins All Children's (St. Petersburg)
- St. Joseph's Children's Hospital (Tampa)
-
Kentucky
- University of Kentucky (Lexington)
-
Maryland
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (Baltimore)
-
Missouri
- Washington University St. Louis (St Louis)
-
New York
- Montefiore Medical Center (The Bronx)
-
North Carolina
- UNC Lineberger Comprehensive Cancer Center (Chapel Hill)
- Levine Cancer Institute (Charlotte)
-
Tennessee
- Vanderbilt University Medical Center (Nashville)
-
Texas
- UT Southwestern (Dallas)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.